• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUBING; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUBING; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Device Problem Component Missing (2306)
Patient Problem Blurred Vision (2137)
Event Date 02/17/2023
Event Type  Injury  
Event Description
Patient given ertapenem injection 1g per day to be infused.Patient reported no issues in first few days.For 2 days, patient reported blurry vision (which would last 10-15 minutes) approximately 4 hours after infusion.Patient informed that his tubing didn't have a filter the 2 days he got symptoms, and when the filter was used again, the blurry vision stopped.Anecdotal, but lack of filter may increase side effects?.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TUBING
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
MDR Report Key16438063
MDR Text Key310318250
Report NumberMW5115174
Device Sequence Number1
Product Code FPA
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 02/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/23/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Age55 YR
Patient SexMale
Patient Weight88 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-